Cantor Fitzgerald Reiterates “Overweight” Rating for BioMarin Pharmaceutical (NASDAQ:BMRN)
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Free Report)‘s stock had its “overweight” rating reissued by investment analysts ...
dailyfreeman.com12h
How they voted: Schumer, Gillibrand on FBI director confirmation
Here’s a look at how area members of Congress voted over the previous week. There were no key votes in the House this week.
US Senate Confirms Cantor Fitzgerald's Lutnick to Head Commerce Department
Senate Commerce Committee chair Ted Cruz said Lutnick will focus on issues including expanding commercial access to wireless ...
US Commerce Secretary Howard Lutnick's Cantor Fitzgerald Increases Bitcoin Exposure Via ETFs, MSTR, MARA; Adds Chinese Firms Like BABA, Baidu, JD In Q4
US Commerce Secretary Howard Lutnick‘s hedge fund Cantor Fitzgerald LP increased the firm’s exposure to Bitcoin (CRYPTO: BTC) ...
Brokers Offer Predictions for VRTX FY2025 Earnings
Cantor Fitzgerald issued their FY2025 EPS estimates for shares of Vertex Pharmaceuticals in a research note issued to ...
Daily Camera17h
How They Voted: Colorado congressional votes for Feb. 14-20, 2025
REGULATORY POWER: The Senate has approved an amendment sponsored by Sen. Mike Lee, R-Utah, to a budget resolution (S. Con.
Hosted on MSN2d
Cantor Fitzgerald Downgrades Supernus Pharmaceuticals (SUPN)
Fintel reports that on February 19, 2025, Cantor Fitzgerald downgraded their outlook for Supernus Pharmaceuticals ...
Nice price target lowered to $161 from $176 at Cantor Fitzgerald
Cantor Fitzgerald lowered the firm’s price target on Nice (NICE) to $161 from $176 and keeps a Neutral rating on the shares. Nice reported ...
Rivian downgraded by Cantor on weak 2025 delivery outlook
Cantor Fitzgerald downgraded Rivian Automotive (NASDAQ:RIVN) to Neutral from Overweight given a weaker-than-expected 2025 delivery outlook and macroeconomic challenges, including new tariffs and the ...